A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin

A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin

Bibliographic Details
Main Authors:	Alexa DeMaio, MD, Kimberly B. Hashemi, MD, Alexandria Avery, MD, John S. Metcalf, MD, Laura S. Winterfield, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	JAAD Case Reports
Subjects:	checkpoint inhibitor immune-related adverse event IVIG scleroderma-like syndrome
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622002636

Similar Items

Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
by: Neda Shahriari, MD, et al.
Published: (2023-02-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
by: Jason Kieffer, MD, et al.
Published: (2024-03-01)

Intravenous Immunoglobulin Therapy in COVID-19 Disease
by: Öner Özdemir, et al.
Published: (2021-06-01)

The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01)

Comparative study between the efficacy of Intravenous Immunoglobulin alone versus the efficacy of Intravenous Immunoglobulin combined with Steroids in treatment of Acute Myocarditis in Pediatric patients in Qena University Hospital
by: Alaa Abd El-sabour Bashier, et al.
Published: (2024-01-01)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
by: Sandra Reznik, et al.
Published: (2022-07-01)

Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
by: Rosario Foti, et al.
Published: (2021-11-01)

New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults
by: Chih-Jen Chen, et al.
Published: (2024-01-01)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
by: Thomas Rogier, et al.
Published: (2020-06-01)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017-05-01)

Human otopathology in scleroderma
by: Melissa Castillo‐Bustamante, et al.
Published: (2023-12-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Ludger Feyen, et al.
Published: (2023-03-01)

Esclerodermia localizada: Diagnósticos diferenciales Localized scleroderma: Differential diagnosis
by: MB Leroux, et al.
Published: (2011-09-01)

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages
by: Chaitrali Saha, et al.
Published: (2020-02-01)

Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease
by: Sadeep Shrestha, et al.
Published: (2024-01-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

Antiphospholipid Antibodies and Systemic Scleroderma
by: Muhammed Mubarak, et al.
Published: (2013-12-01)

Scleroderma-overlap syndromes: capillaroscopy, laboratory, and clinical manifestations and follow-up compared to scleroderma patients
by: Saeedeh Shenavandeh, et al.
Published: (2024-01-01)

Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia
by: Rick Kapur, et al.
Published: (2017-07-01)

Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report
by: Maryam Daneshpazhooh, et al.
Published: (2020-07-01)

Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review
by: Pinyowiwat P, et al.
Published: (2023-04-01)

Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
by: Dominik Jarczak, et al.
Published: (2020-08-01)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
by: Tsvetelina Velikova, et al.
Published: (2023-03-01)

The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated
by: Serdar EFE, et al.
Published: (2024-02-01)

Antiphospholipid Antibodies and Systemic Scleroderma
by: Awa Oumar Touré, et al.
Published: (2013-03-01)

SCLERODERMA: A CASE REPORT*
by: Gülay Altan, et al.
Published: (2015-04-01)

Connective tissue nevus misdiagnosed as juvenile localized scleroderma
by: F. Tirelli, et al.
Published: (2023-10-01)

SCLERODERMA NEPHROPATHY: UNSOLVED PROBLEMS
by: I. E. Bulavko, et al.
Published: (2021-10-01)

A case of localized bullous scleroderma
by: A. L. Bakulev, et al.
Published: (2017-08-01)

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
by: Dorota Kwapisz, et al.
Published: (2023-07-01)

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives
by: Leigh A. Stubbs, et al.
Published: (2023-04-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

Hyaluronic Acid Filler Injection for Localized Scleroderma – Case Report and Review of Literature on Filler Injections for Localized Scleroderma
by: Sharad J
Published: (2022-08-01)

Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence
by: Luigi Brunetti, et al.
Published: (2023-02-01)

Intravenous Immunoglobulin (IVIG) Therapy for COVID-19 Omicron (B.1.1.529) Variant with Acute Respiratory Distress Syndrome
by: Dewi Arum Sawitri, et al.
Published: (2023-01-01)

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review
by: Ge Xiong, et al.
Published: (2023-07-01)

Drug-induced scleroderma-like lesion
by: Yasuhito Hamaguchi
Published: (2022-04-01)

Association between Localized Scleroderma Cutaneous Assessment Tool and clinicopathologic characteristics in patients with morphea
by: Yıldız Gürsel Ürün, et al.
Published: (2022-09-01)

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients
by: Rui Zhang, et al.
Published: (2023-06-01)